NeuPath and Cynergi will bring VR therapy to chronic pain management
NeuPath will integrate Cynergi’s VR program with its remote pain management platform

NeuPath has signed a Memorandum of Understanding (MoU) with Cynergi to assess the efficacy of the company's virtual reality (VR) program for chronic pain management.
“Chronic pain is the leading cause of disability worldwide. Studies estimate the cost of this lost productivity to be in excess of $300 billion per year in the US alone,” said Harbir Singh, Cynergi CEO.
Singh added: “Collaborating with NeuPath and building a holistic chronic pain targeted treatment program provides an outstanding opportunity to work with employers and other payers to improve patient quality of life while also reducing disability-related costs as well as other direct health care costs.”
Per the new deal, Cynergi’s Rilaxta VRx will be used alongside NeuPath’s remote pain management and virtual care platform across Canada and the US.
Adding VR software to traditional interventions can provide extensive benefits in behavioral pain management.
Cynergi’s proprietary virtual reality tools pair soothing images and sound with proven psychological techniques to reduce anxiety and panic. Developed by renowned Harvard psychiatrist Arshya Vahabzadeh, Cynergi’s VR program also includes guided therapy for benzodiazepine, alcohol, and opioid addiction.
NeuPath’s centers for pain management provide multimodal treatments for patients with chronic pain. Together, Cynergi and NeuPath aim to offer customized VR treatment plans for psychological and behavioral pain.
Sign up today and you will receive a free copy of our Future Focus 2025 report - the leading guidance on AI, cybersecurity and other IT challenges as per 700+ senior executives
Earlier this month, NeuPath acquired virtual care platform KumoCare. Designed to reduce wait times, KumoCare enables secure video chat with medical practitioners.
-
Pure Storage pulls no punches with competitors amid Enterprise Data Cloud launch
News The new data cloud is evolutionary, not revolutionary, but Pure thinks it's still the best option on the market
-
AMD Advancing AI 2025: Racks, openness, and the spectre of Nvidia
Opinion Can the chipmaker really step out of the market leader's shadow?
-
NHS set for huge tech investment boost in latest spending review
News The government spending review will fund the NHS App, the single patient record, the Federated Data Platform, and other initiatives
-
Has Lenovo found the ultimate business use case for smart glasses?
Opinion Lenovo’s T1 smart glasses offer a virtual desktop that only you can see
-
Cambridge-1 and the future of medicine
Case Studies Nvidia’s first public supercomputer could change healthcare in the UK and around the world
-
NIH renews COVID research contract with Palantir
News Palantir will create a cloud-based data enclave to support COVID-19 research collaborations
-
Virtual striker: Using VR to train Premier League stars
Case Studies How one company is taking VR out of the boardroom and into the locker room
-
Sensome’s AI-powered stroke guidewire begins human trials in Australia
News The trial adds to Sensome’s multicenter CLOT OUT study
-
Yext’s Find-a-Doc streamlines finding a doctor with AI
News The platform provides smart suggestions to improve patients' pre-appointment experience
-
VEON's Beeline to bring mobile AI to health care
News Beeline will work with Sechenov Medical University to promote early diagnosis of life-threatening conditions